Bendazac
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Topical |
| ATC code | M02AA11 (WHO) S01BC07 (WHO) |
| Identifiers | |
| |
| CAS Number |
20187-55-7  Y |
| PubChem (CID) | 2313 |
| ChemSpider |
2223 Y |
| UNII |
G4AG71204O Y |
| KEGG |
D01594 Y |
| ChEBI |
CHEBI:31257  N |
| ChEMBL |
CHEMBL1089221 Y |
| Chemical and physical data | |
| Formula | C16H14N2O3 |
| Molar mass | 282.294 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| NY (what is this?) (verify) | |
Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain.
Synthesis
Principal action is inhibition of protein denaturation.
Bendazac synthesis: BE 699226 ; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).
Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).
See also
References
| Pyrazolones / Pyrazolidines | |
|---|---|
| Salicylates | |
| Acetic acid derivatives and related substances | |
| Oxicams | |
| Propionic acid derivatives (profens) |
|
| N-Arylanthranilic acids (fenamates) | |
| Coxibs | |
| Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. | |
| Anti-inflammatory preparations, non-steroids |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capsaicin derivatives | |||||||||||
| Other | |||||||||||
This article is issued from Wikipedia - version of the 10/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.